Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clodronate for prevention of bone metastases in primary breast cancer
ISRCTN83688026Phase 3Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Jan 1989
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of clodronate in breast cancer (2 arms), sponsored by Royal Marsden NHS Foundation Trust. Primary endpoint: Time to first bone metastases. Started Jan 1989; status: completed.
02
Drugs
clodronate
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN83688026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN83688026.